Conference Description:

Join and network with over 400 industry leaders at the renowned Drug Discovery Summit in Berlin, where we will address the latest advancements in target identification, validation and HIT optimisation.

Exploring the latest advancements in phenotypic and target-based discovery, chemical biology as well as drug design at our two-day summit.

The event will bring together leading experts in the fields of Organoid Discovery, Phenotypic Screening, Targeted Protein Degradation, AI Computational Drug Design and Lead Optimisation.

The 2023 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Below were some of the key speakers from our Discovery Europe 2022 event.

Malcolm Weir, Executive Officer, Vice President at Sosei Heptares

Ulrich Betz, Vice President Innovation, Head of Department Innovation Incubator at Merck

Matthias Frech, Director, Molecular Interactions & Biophysics
at Merck

Clara Christ, Head of Computational Molecular Design at
Bayer

Olivier Nosjean, Head of Open Innovation and Scientific Affairs, R&D at Servier

Nadeem Sarwar, Global Head, Genomic Strategies & Global Head, Digital Therapeutics (DTx) Strategies at Eisai